Correlation Between Pacira Pharmaceuticals and Dr Reddys

Can any of the company-specific risk be diversified away by investing in both Pacira Pharmaceuticals and Dr Reddys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pacira Pharmaceuticals and Dr Reddys into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pacira Pharmaceuticals and Dr Reddys Laboratories, you can compare the effects of market volatilities on Pacira Pharmaceuticals and Dr Reddys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pacira Pharmaceuticals with a short position of Dr Reddys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pacira Pharmaceuticals and Dr Reddys.

Diversification Opportunities for Pacira Pharmaceuticals and Dr Reddys

0.36

Correlation Coefficient

Pacira Pharmaceuticals  Dr Reddys

Weak diversification

The 3 months correlation between Pacira and RDY is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Pacira Pharmaceuticals and Dr Reddys Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dr Reddys Laboratories and Pacira Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pacira Pharmaceuticals are associated (or correlated) with Dr Reddys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dr Reddys Laboratories has no effect on the direction of Pacira Pharmaceuticals i.e., Pacira Pharmaceuticals and Dr Reddys go up and down completely randomly.

Pair Corralation between Pacira Pharmaceuticals and Dr Reddys

Given the investment horizon of 90 days Pacira Pharmaceuticals is expected to under-perform the Dr Reddys. In addition to that, Pacira Pharmaceuticals is 1.83 times more volatile than Dr Reddys Laboratories. It trades about -0.09 of its total potential returns per unit of risk. Dr Reddys Laboratories is currently generating about 0.05 per unit of volatility. If you would invest  7,285  in Dr Reddys Laboratories on February 4, 2024 and sell it today you would earn a total of  236.00  from holding Dr Reddys Laboratories or generate 3.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Pacira Pharmaceuticals  vs.  Dr Reddys Laboratories

Pacira Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pacira Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Dr Reddys Laboratories

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Dr Reddys Laboratories are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong fundamental indicators, Dr Reddys is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Pacira Pharmaceuticals and Dr Reddys

The main advantage of trading using opposite Pacira Pharmaceuticals and Dr Reddys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pacira Pharmaceuticals position performs unexpectedly, Dr Reddys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dr Reddys will offset losses from the drop in Dr Reddys' long position.

The idea behind Pacira Pharmaceuticals and Dr Reddys Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.